Mike Khouw Looks At Rocket Companies’ Options Activity: More Weakness Ahead? – Rocket Companies, Inc. (RKT)

Shares of Rocket Companies Inc (NYSE:RKT) have lost over 30{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} over the past year and are down close to 6{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} year to date.

On CNBC’s “Options Action,” Mike Khouw of Optimize Advisors said the stock traded 7.6 times its average daily put volume on Thursday.

See Also: Rocket Mortgage Super Bowl Squares Sweepstakes Returns For A Big Third Year

A large bearish bet came in the form of the purchase of 25,000 of the March 14/10 put spreads for an average price of $1.04 per contract, Khouw mentioned. The trade represents 2.5 million shares.

The trader expects shares of Rocket Companies to lose as much as 28{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} over the next couple of months.

“So, at least one institutional investor sees further weakness ahead,” Khouw said.

Source link

Read more

Define Health Education

Why Online Health Education Can Be The Best

In a bid to significantly reduce the amount of health infections and problems throughout the world,many international organizations and other government agencies have resorted to using the internet as the best platform of providing education to people. Health education helps the people to acquire knowledge on the kind of lifestyle they should live or avoid plus the measures they can take to prevent or reduce the occurrence of some common or chronic diseases. There are a many reasons that make online provision of health education the best method of sensitizing people on health issues. The following reasons seek to explain why online training is the most effective compared to the use of other methods.

Minimal resources are used in the sensitization process

The emergence of technology has seen many business people and other humanitarian organizations providing their goods and services online. The

Read more

10 Biggest Price Target Changes For Thursday

  • RBC Capital boosted KB Home (NYSE: KBH) price target from $46 to $55. KB Home shares rose 6.7{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to $45.20 in pre-market trading.
  • Cowen & Co. reduced the price target on Snap Inc. (NYSE: SNAP) from $75 to $45. Snap shares fell 2.9{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to $41.50 in pre-market trading.
  • MKM Partners boosted Mattel, Inc. (NASDAQ: MAT) price target from $24 to $30. Mattel shares rose 1.5{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to $22.32 in pre-market trading.
  • Keybanc raised the price target for AvalonBay Communities, Inc. (NYSE: AVB) from $255 to $275. AvalonBay Communities shares rose 0.6{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to close at $250.72 on Wednesday.
  • Guggenheim lowered Biogen Inc. (NASDAQ: BIIB) price target from $290 to $202. Biogen shares fell 1.1{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to $222.82 in pre-market trading.
  • Credit Suisse lifted Nelnet, Inc. (NYSE: NNI) price target from $92 to $96. Nelnet shares fell 0.7{b02bdf04de3f9bc06c998e855c65941e7d8f5cd012e86469a83340818e6b6d52} to $94.00 in pre-market trading.
  • Keybanc lifted the price target on ConocoPhillips (NYSE: COP) from $81
Read more

Cardiovascular Systems, Inc. (NASDAQ:CSII) – Cardiovascular Systems Recalls Embolic Protection Devices Due To Filter Breakage

Cardiovascular Systems Inc (NASDAQ: CSII) is recalling all of its Wirion embolic protection system devices manufactured and distributed between January and November 2021.

  • The Wirion system includes a filter inserted through a blood vessel in the leg via a catheter. 
  • The filter catches and removes any blood clots or debris floating in the bloodstream during an atherectomy procedure to remove plaque build-ups linked to peripheral artery disease.
  • In some cases, however, including when the filter basket becomes too full, the Wirion device may be challenging to withdraw using the retrieval catheter, potentially causing the filter to tear or separate from the catheter. 
  • If that happens, it could require further medical procedures, allow a blood clot or other material to block the bloodstream, or lead to other serious complications, including death.
  • Because of that potential risk, the FDA has given Cardiovascular Systems’ recall a Class I rating.
  • In late November, the
Read more

(SANA) – Sana Biotechnology Inks Two Licensing Pacts For Targets Against Hematological Malignancies

Sana Biotechnology Inc (NASDAQ: SANA) has obtained non-exclusive commercial rights to a clinically validated fully-human BCMA CAR construct from IASO Biotherapeutics and Innovent Biologics.

  • The constructs can be used in certain in vivo gene therapy and ex vivo hypoimmune cell therapy applications. 
  • IASO Bio and Innovent will receive an upfront payment and are entitled to receive up to approximately $204 million in potential development and regulatory milestone payments across up to six products, as well as royalties.
  • Related: Sana Obtains License To Beam Therapeutics’ CRISPR Cas12b Gene Editing Technology.
  • B cell maturation antigen (BCMA) has been validated as a target for autologous CAR T therapy in relapsed and/or refractory multiple myeloma.
  • Separately, Sana Biotechnology has entered into an agreement with the National Cancer Institution (NCI) for worldwide exclusive commercial rights to the NIH’s CD22 chimeric antigen receptor (CAR) with a fully-human binder for use in certain in vivo
Read more